In an article published by Law360, Partner Chris Barnstable-Brown discusses the M&A appetite he’s seen in healthcare this year, pointing to companies starting to find a path forward from the valuation, interest rates and regulatory hurdles that emerged in 2022.
Excerpt: “While deals were made cautiously, bigger companies did start to open up their wallets to buy new assets. Smaller players also began to sell at valuations that weren't blockbusters but were still attractive.
‘I think there's been a little bit of folks merging on valuations after the last 12 to 18 months of pressure and interest rates,’ Barnstable-Brown said. ‘That's when you see deals get done — when there's a meeting of the minds and meeting of valuations.’”